Literature DB >> 35226070

Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse.

Monica Chivulescu1,2, Eivind W Aabel1,2, Erik Gjertsen3, Einar Hopp4, Esther Scheirlynck5, Bernard Cosyns5, Erik Lyseggen1, Thor Edvardsen1,2, Øyvind H Lie1,2, Lars A Dejgaard1, Kristina H Haugaa1,2,6,7.   

Abstract

AIMS: We aimed to characterize the substrate of T-wave inversion (TWI) using cardiac magnetic resonance (CMR) and the association between diffuse fibrosis and ventricular arrhythmias (VA) in patients with mitral valve prolapse (MVP). METHODS AND
RESULTS: TWI was defined as negative T-wave ≥0.1 mV in ≥2 adjacent ECG leads. Diffuse myocardial fibrosis was assessed by T1 relaxation time and extracellular volume (ECV) fraction by T1-mapping CMR. We included 162 patients with MVP (58% females, age 50 ± 16 years), of which 16 (10%) patients had severe VA (aborted cardiac arrest or sustained ventricular tachycardia). TWI was found in 34 (21%) patients. Risk of severe VA increased with increasing number of ECG leads displaying TWI [OR 1.91, 95% CI (1.04-3.52), P = 0.04]. The number of ECG leads displaying TWI increased with increasing lateral ECV (26 ± 3% for TWI 0-1leads, 28 ± 4% for TWI 2leads, 29 ± 5% for TWI ≥3leads, P = 0.04). Patients with VA (sustained and non-sustained ventricular tachycardia) had increased lateral T1 (P = 0.004), also in the absence of late gadolinium enhancement (LGE) (P = 0.008).
CONCLUSIONS: Greater number of ECG leads with TWI reflected a higher arrhythmic risk and higher degree of lateral diffuse fibrosis by CMR. Lateral diffuse fibrosis was associated with VA, also in the absence of LGE. These results suggest that TWI may reflect diffuse myocardial fibrosis associated with VA in patients with MVP. T1-mapping CMR may help risk stratification for VA.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Diffuse myocardial fibrosis; Electrocardiography; Mitral valve prolapse; T1-mapping cardiac magnetic resonance; Ventricular arrhythmias

Mesh:

Substances:

Year:  2022        PMID: 35226070      PMCID: PMC9301977          DOI: 10.1093/europace/euac017

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.486


  20 in total

Review 1.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Authors:  Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

Review 2.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.

Authors:  William A Zoghbi; David Adams; Robert O Bonow; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Rebecca T Hahn; Yuchi Han; Judy Hung; Roberto M Lang; Stephen H Little; Dipan J Shah; Stanton Shernan; Paaladinesh Thavendiranathan; James D Thomas; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2017-03-14       Impact factor: 5.251

3.  Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.

Authors:  Danai Kitkungvan; Faisal Nabi; Raymond J Kim; Robert O Bonow; Mohammad A Khan; Jiaqiong Xu; Stephen H Little; Miguel A Quinones; Gerald M Lawrie; William A Zoghbi; Dipan J Shah
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

Review 4.  Myocardial Tissue Characterization and Fibrosis by Imaging.

Authors:  Theodoros D Karamitsos; Alexandra Arvanitaki; Haralambos Karvounis; Stefan Neubauer; Vanessa M Ferreira
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18

5.  Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.

Authors:  Benjamin Essayagh; Avi Sabbag; Clémence Antoine; Giovanni Benfari; Li-Tan Yang; Joseph Maalouf; Samuel Asirvatham; Hector Michelena; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2020-08-11       Impact factor: 24.094

Review 6.  State of the Art: Clinical Applications of Cardiac T1 Mapping.

Authors:  Erik B Schelbert; Daniel R Messroghli
Journal:  Radiology       Date:  2016-03       Impact factor: 11.105

7.  Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death.

Authors:  Hui-Chen Han; Sarah A Parsons; Claire L Curl; Andrew W Teh; Antonia J A Raaijmakers; Anoop N Koshy; Trishe Leong; Louise M Burrell; David O'Donnell; Jitendra K Vohra; Jonathan M Kalman; Prashanthan Sanders; David L Hare; Omar Farouque; Lea M D Delbridge; Han S Lim
Journal:  Heart Rhythm       Date:  2020-12-24       Impact factor: 6.343

8.  Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Authors:  Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard B Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2018-02-07       Impact factor: 5.364

9.  Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias.

Authors:  Esther Scheirlynck; Lars A Dejgaard; Eystein Skjølsvik; Oyvind H Lie; Andreea Motoc; Einar Hopp; Kaoru Tanaka; T Ueland; Margareth Ribe; Carlos Collet; Thor Edvardsen; Steven Droogmans; Bernard Cosyns; Kristina H Haugaa
Journal:  Open Heart       Date:  2019-04-28

Review 10.  Assessment of myocardial fibrosis with T1 mapping MRI.

Authors:  R J Everett; C G Stirrat; S I R Semple; D E Newby; M R Dweck; S Mirsadraee
Journal:  Clin Radiol       Date:  2016-03-19       Impact factor: 2.350

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.